These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27156586)

  • 1. The Application of PET in Radiation Treatment Planning for Head and Neck Cancer.
    Woods C; Sohn J; Yao M
    PET Clin; 2011 Apr; 6(2):149-63. PubMed ID: 27156586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Treatment Planning for Head and Neck Cancer with PET.
    Woods C; Sohn J; Machtay M; Yao M
    PET Clin; 2012 Oct; 7(4):395-410. PubMed ID: 27157646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer.
    Dandekar P; Partridge M; Kazi R; Nutting C; Harrington K; Newbold K
    Indian J Cancer; 2010; 47(3):260-6. PubMed ID: 20587900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Treatment Planning for Head and Neck Malignancies.
    de Andrade RS; Heron DE
    PET Clin; 2007 Oct; 2(4):511-9. PubMed ID: 27158110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers.
    Awan MJ; Siddiqui F; Schwartz D; Yuan J; Machtay M; Yao M
    World J Radiol; 2015 Nov; 7(11):382-93. PubMed ID: 26644824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of PET/CT on planning of radiotherapy in head and neck cancer.
    Minn H; Suilamo S; Seppälä J
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):521-32. PubMed ID: 20927019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
    Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deformable registration of preoperative PET/CT with postoperative radiation therapy planning CT in head and neck cancer.
    Kovalchuk N; Jalisi S; Subramaniam RM; Truong MT
    Radiographics; 2012; 32(5):1329-41. PubMed ID: 22977021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in imaging: target delineation.
    Hunter KU; Eisbruch A
    Cancer J; 2011; 17(3):151-4. PubMed ID: 21610467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of FDG-PET/CT in Cervical Cancer: Diagnosis, Staging, Radiation Treatment Planning and Follow-Up.
    Haynes-Outlaw ED; Grigsby PW
    PET Clin; 2010 Oct; 5(4):435-46. PubMed ID: 27157971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular PET/CT imaging-guided radiation therapy treatment planning.
    Zaidi H; Vees H; Wissmeyer M
    Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
    Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
    J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
    Nawara C; Rendl G; Wurstbauer K; Lackner B; Rettenbacher L; Datz L; Studnicka M; Sedlmayer F; Pirich C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):191-201. PubMed ID: 22402822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of advanced imaging technologies for target delineation in radiation oncology.
    Simpson DR; Lawson JD; Nath SK; Rose BS; Mundt AJ; Mell LK
    J Am Coll Radiol; 2009 Dec; 6(12):876-83. PubMed ID: 19945044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT Initial and Subsequent Therapy Evaluation: Progressing to PET/MR Imaging.
    Mosci C; Davidzon GA; Quon A
    PET Clin; 2012 Oct; 7(4):369-80. PubMed ID: 27157644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical Aspects of PET/CT-Based Radiotherapy Planning.
    Fox T; Lawson J; Schreibmann E
    PET Clin; 2011 Apr; 6(2):117-29. PubMed ID: 27156584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT in Radiotherapy Planning for Head and Neck Cancer.
    Newbold K; Powell C
    Front Oncol; 2012; 2():189. PubMed ID: 23233906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating PET information in radiation therapy planning.
    Macmanus M; Leong T
    Biomed Imaging Interv J; 2007 Jan; 3(1):e4. PubMed ID: 21614264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in image-guided radiotherapy for head and neck carcinoma.
    Nath SK; Simpson DR; Rose BS; Sandhu AP
    J Oncol; 2009; 2009():752135. PubMed ID: 19644564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.